- ►annals.org [PDF] RR Recker, KM Davies, RM Dowd, RP … - Annals of internal medicine, 1999 - Am Coll Physicians Symptoms related to HRT (breast tenderness, spotting, pelvic discomfort, and
mood changes) were mild and short-lived. Conclusions: Continuous low-dose HRT
with conjugated equine estrogen and oral medroxyprogesterone combined with ... Cited by 232 - Related articles - BL Direct - All 8 versions
HK Genant, J Lucas, S Weiss, M Akin, R … - Archives of Internal Medicine, 1997 - archinte.highwire.org Page 1. Low-Dose Esterified Estrogen Therapy Effects on Bone, Plasma Estradiol
Concentrations, Endometrium, and Lipid Levels Harry ... Cited by 228 - Related articles - BL Direct - All 6 versions
- ►kimsonline.co.kr [PDF] R Lindsay, JC Gallagher, M Kleerekoper, JH … - Jama, 2002 - Am Med Assoc Context Lower-than-commonly-prescribed doses of conjugated equine estrogens
(CEEs) with medroxyprogesterone acetate (MPA) improve vasomotor symptoms and
vaginal atrophy, provide acceptable bleeding and lipid profiles, and afford ... Cited by 293 - Related articles - BL Direct - All 5 versions
H Mizunuma, H Okano, M Soda, I Kagami, S … - Maturitas, 1997 - Elsevier Objective: To re-examine the minimal effective dose of conjugated estrogen
(CEE)-progestin hormone replacement on postmenopausal bone loss. Design: A
2-year, prospective, open label, randomized study. Setting: Department of ... Cited by 55 - Related articles - All 6 versions
B ETTINGER, HK GENANT, P STEIGER, P … - Obstetrical & Gynecological Survey, 1992 - journals.lww.com Menopause 649 ing age. Thus, it is possible that aging, rather than estrogen
replacement therapy, may be a key factor in venous thrombosis in postmeno-
pausal women. As I mentioned earlier, there are several short- comings to ... Cited by 139 - Related articles - BL Direct - All 4 versions
- ►cenegenicsfoundation.org [PDF] SR Weiss, H Ellman, M Dolker - Obstetrics & Gynecology, 1999 - journals.lww.com The Transdermal Estradiol Investigator Group includes Richard Bath, MD, and
Jeanne Blevins, Cincinnati, OH; Sidney Funk, MD, and Stacy Beasley, RN, Atlanta,
GA; Russell Graham, MD, and Wendy Centers-Cornell, RN, Altamonte Springs, ... Cited by 62 - Related articles - BL Direct - All 8 versions
- ►endojournals.org KM Prestwood, AM Kenny, C Unson, M … - Journal of Clinical Endocrinology & Metabolism, 2000 - Endocrine Soc The purpose of this study was to examine the effects of three doses (0.25, 0.5,
and 1.0 mg/day) of micronized 17ß-estradiol on bone turnover, sex hormone
levels, and side effects compared with placebo in healthy older women. The ... Cited by 72 - Related articles - BL Direct - All 8 versions
SF Evans, MWJ Davie - Clinical Endocrinology, 1996 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 70 - Related articles - BL Direct - All 5 versions
DL Schneider, EL Barrett-Connor, DJ Morton … - Jama, 1997 - Am Med Assoc Diane L. Schneider, MD; Elizabeth L. Barrett-Connor, MD; Deborah J. Morton, MA ... Objective.—To determine the effect of the timing of initiation and the
duration of postmenopausal estrogen therapy on bone mineral density (BMD). ... Cited by 215 - Related articles - View as HTML - BL Direct - All 6 versions
- ►endojournals.org M Komulainen, H Kroger, MT Tuppurainen, AM … - Journal of Clinical Endocrinology & Metabolism, 1999 - Endocrine Soc The long term effects of hormone replacement therapy (HRT) and vitamin D 3 (Vit
D) on bone mineral density (BMD) were studied. A total of 464 nonosteoporotic
early postmenopausal women from the Kuopio Osteoporosis Study (n = 13100) ... Cited by 65 - Related articles - BL Direct - All 6 versions
